Carl Anthony Evans, Director at CNS Pharmaceuticals, Inc. (CNSP), bought 33,333 shares at $0.30 ($10K) on 2024-02-01, disclosed to the SEC on 2024-02-06.
Open-market purchase of $10k CNSP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.